PIOSG00015W
FGF2 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIOSG00015W-Each-of-1 | In Stock | ₹ 42,720.00 |
PIOSG00015W - Each of 1
In Stock
Quantity
1
Base Price: ₹ 42,720.00
GST (18%): ₹ 7,689.60
Total Price: ₹ 50,409.60
Antigen
FGF2
Classification
Polyclonal
Gene
FGF2
Gene Alias
BFGF, FGFB, HBGF-2, prostatropin
Host Species
Rabbit
Quantity
150 μL
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG
Applications
Immunohistochemistry, Western Blot
Conjugate
Unconjugated
Gene Accession No.
P09038, P15655, P13109
Gene Symbols
FGF2
Immunogen
A synthetic peptide from the internal region of human basic FGF conjugated to an immunogenic carrier protein
Regulatory Status
RUO
Gene ID (Entrez)
14173, 2247, 54250
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Lyophilized
Related Products
Description
- The immunogen is homologous in many other species including zebrafish
- Reconstitute in 150 μL of sterile water
- FGF2 (FGFb, fibroblast growth factor basic) belongs to the fibroblast growth factor (FGF) family, and interacts with high-affinity transmembrane receptors to influence cell proliferation and tissue neovascularization
- FGF2 exists as five isoforms with distinct intracellular localizations and functions
- The 18 kDa isoform is predomitly cytosolic and acts through cell surface receptors, whereas the 22, 22.5, 24 and 34 kDa isoforms are nuclear and may signal independent of transmembrane receptor pathways
- In humans, the gene is located on the q arm of chromosome 4
- FGF2 has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth
- The mRNA for FGF2 contains multiple polyadenylation sites, and is alternatively translated from non-AUG and AUG initiation codons, resulting in five different isoforms with distinct properties
- The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF
- Diseases associated with FGF2 dysfunction include Kaposi Sarcoma and corneal neovascularization.